The Guardian

Věda a technika

How effective is the new Alzheimer’s drug aducanumab?

Science Weekly

Twice a week, the Guardian brings you the latest science and environment news

 Before Covid, dementia was the biggest killer in the UK and Alzheimer’s disease is the most common type. A controversial new drug for Alzheimer’s, aducanumab, is the first in nearly 20 years to be approved in the US, which will trigger pressure to make it available worldwide. The Guardian’s health editor, Sarah Bosley, talks Shivani Dave through the mixed evidence of its efficacy. Help support our independent journalism at <a href="https://www.theguardian.com/sciencepod">theguardian.com/sciencepod</a> 

Aplikace Youradio Talk

Pro přehrání dalších podcastů se prosím registrujte.

How effective is the new Alzheimer’s drug aducanumab?

Poslechněte si podcast